Market Executive Summary
Market Analysis and Insights: Global and United States Adeno-Associated Virus (AAV) Gene Therapy Market
This report focuses on global and United States Adeno-Associated Virus (AAV) Gene Therapy market, also covers the segmentation data of other regions in regional level and county level.
The global Adeno-Associated Virus (AAV) Gene Therapy revenue was US$ 1637 million in 2022 and is forecast to a readjusted size of US$ 2957.5 million by 2029 with a CAGR of 8.8% during the review period (2023-2029).
The global key players of Adeno-Associated Virus (AAV) Gene Therapy include Creative Biolabs, Affinia Therapeutics, Spark Therapeutics, AGC Biologics, StrideBio, SIRION Biotech, Neurophth Biotechnology, Belief BioMed and BiBo Biopharma Engineering Co., LTD., etc. The global five biggest players hold a share of % in 2022.
Global Adeno-Associated Virus (AAV) Gene Therapy Scope and Market Size
Adeno-Associated Virus (AAV) Gene Therapy market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Adeno-Associated Virus (AAV) Gene Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.
For United States market, this report focuses on the Adeno-Associated Virus (AAV) Gene Therapy market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in United States.
By Company
Creative Biolabs
Affinia Therapeutics
Spark Therapeutics
AGC Biologics
StrideBio
SIRION Biotech
Neurophth Biotechnology
Belief BioMed
BiBo Biopharma Engineering Co., LTD.
Beihai Kangcheng
PackGene Biotech
Sarepta Therapeutics
Carbon BioSciences
Kelonia Therapeutics
Roche
Remedium Bio
Segment by Type
Luxturna
Zolgensma
Others
Segment by Application
Central Nervous System Diseases
Ocular Diseases
Liver-directed Diseases
Other Hereditary Diseases
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1: Introduces Adeno-Associated Virus (AAV) Gene Therapy definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Adeno-Associated Virus (AAV) Gene Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5: Revenue of Adeno-Associated Virus (AAV) Gene Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6: Americas by type, by application and by country revenue for each segment.
Chapter 7: EMEA by type, by application and by region, revenue for each segment.
Chapter 8: China by type, by application revenue for each segment.
Chapter 9: APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Adeno-Associated Virus (AAV) Gene Therapy revenue, gross margin and recent development, etc.
Chapter 11: Analyst's Viewpoints/Conclusions
Related Reports:
Global Advanced Cell Therapies Market Analysis, Share, Opportunities, Growth Trends and Forecast Till 2030
Global T-Cell Therapy Market Analysis, Share, Opportunities, Growth Trends and Forecast Till 2030
Global Gene Therapy Market Analysis, Growth Drivers, Trends, Recent Developments, and Forecast Till 2030
Table of Contents
1 Study Coverage
1.1 Adeno-Associated Virus (AAV) Gene Therapy Product Introduction
1.2 Global Adeno-Associated Virus (AAV) Gene Therapy Outlook 2018 VS 2022 VS 2029
1.2.1 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size for the Year 2018-2029
1.2.2 United States Adeno-Associated Virus (AAV) Gene Therapy Market Size for the Year 2018-2029
1.3 Adeno-Associated Virus (AAV) Gene Therapy Market Size, United States VS Global, 2018 VS 2022 VS 2029
1.3.1 The Market Share of United States Adeno-Associated Virus (AAV) Gene Therapy in Global, 2018 VS 2022 VS 2029
1.3.2 The Growth Rate of Adeno-Associated Virus (AAV) Gene Therapy Market Size, United States VS Global, 2018 VS 2022 VS 2029
1.4 Adeno-Associated Virus (AAV) Gene Therapy Market Dynamics
1.4.1 Adeno-Associated Virus (AAV) Gene Therapy Industry Trends
1.4.2 Adeno-Associated Virus (AAV) Gene Therapy Market Drivers
1.4.3 Adeno-Associated Virus (AAV) Gene Therapy Market Challenges
1.4.4 Adeno-Associated Virus (AAV) Gene Therapy Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Adeno-Associated Virus (AAV) Gene Therapy by Type
2.1 Adeno-Associated Virus (AAV) Gene Therapy Market Segment by Type
2.1.1 Luxturna
2.1.2 Zolgensma
2.1.3 Others
2.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018, 2022 & 2029)
2.3 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2029)
2.4 United States Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018, 2022 & 2029)
2.5 United States Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2029)
3 Adeno-Associated Virus (AAV) Gene Therapy by Application
3.1 Adeno-Associated Virus (AAV) Gene Therapy Market Segment by Application
3.1.1 Central Nervous System Diseases
3.1.2 Ocular Diseases
3.1.3 Liver-directed Diseases
3.1.4 Other Hereditary Diseases
3.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018, 2022 & 2029)
3.3 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2029)
3.4 United States Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018, 2022 & 2029)
3.5 United States Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2029)
4 Global Adeno-Associated Virus (AAV) Gene Therapy Competitor Landscape by Company
4.1 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Company
4.1.1 Global Key Companies of Adeno-Associated Virus (AAV) Gene Therapy, Ranked by Revenue (2022)
4.1.2 Global Adeno-Associated Virus (AAV) Gene Therapy Revenue by Player (2018-2023)
4.2 Global Adeno-Associated Virus (AAV) Gene Therapy Concentration Ratio (CR)
4.2.1 Adeno-Associated Virus (AAV) Gene Therapy Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Adeno-Associated Virus (AAV) Gene Therapy in 2022
4.2.3 Global Adeno-Associated Virus (AAV) Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Adeno-Associated Virus (AAV) Gene Therapy Head office and Area Served
4.4 Global Key Players of Adeno-Associated Virus (AAV) Gene Therapy, Product and Application
4.5 Global Key Players of Adeno-Associated Virus (AAV) Gene Therapy, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Adeno-Associated Virus (AAV) Gene Therapy Market Size by Company
4.7.1 Key Players of Adeno-Associated Virus (AAV) Gene Therapy in United States, Ranked by Revenue (2022)
4.7.2 United States Adeno-Associated Virus (AAV) Gene Therapy Revenue by Players (2021, 2022 & 2023)
5 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region
5.1 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2018-2029)
5.2.1 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region: 2018-2023
5.2.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2024-2029)
6 Americas
6.1 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth 2018-2029
6.2 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type
6.2.1 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023)
6.2.2 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2024-2029)
6.2.3 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Share by Type (2018-2029)
6.3 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application
6.3.1 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023)
6.3.2 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2024-2029)
6.3.3 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Share by Application (2018-2029)
6.4 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth 2018-2029
7.2 EMEA Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type
7.2.1 EMEA Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023)
7.2.2 EMEA Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2024-2029)
7.2.3 EMEA Adeno-Associated Virus (AAV) Gene Therapy Market Share by Type (2018-2029)
7.3 EMEA Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application
7.3.1 EMEA Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023)
7.3.2 EMEA Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2024-2029)
7.3.3 EMEA Adeno-Associated Virus (AAV) Gene Therapy Market Share by Application (2018-2029)
7.4 EMEA Adeno-Associated Virus (AAV) Gene Therapy Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth 2018-2029
8.2 China Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type
8.2.1 China Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023)
8.2.2 China Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2024-2029)
8.2.3 China Adeno-Associated Virus (AAV) Gene Therapy Market Share by Type (2018-2029)
8.3 China Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application
8.3.1 China Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023)
8.3.2 China Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2024-2029)
8.3.3 China Adeno-Associated Virus (AAV) Gene Therapy Market Share by Application (2018-2029)
9 APAC (excluding China)
9.1 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size YoY Growth 2018-2029
9.2 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type
9.2.1 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023)
9.2.2 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2024-2029)
9.2.3 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Share by Type (2018-2029)
9.3 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application
9.3.1 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023)
9.3.2 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2024-2029)
9.3.3 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Share by Application (2018-2029)
9.4 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Facts & Figures by Country (2018, 2022 & 2029)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Creative Biolabs
10.1.1 Creative Biolabs Company Details
10.1.2 Creative Biolabs Business Overview
10.1.3 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Introduction
10.1.4 Creative Biolabs Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
10.1.5 Creative Biolabs Recent Development
10.2 Affinia Therapeutics
10.2.1 Affinia Therapeutics Company Details
10.2.2 Affinia Therapeutics Business Overview
10.2.3 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Introduction
10.2.4 Affinia Therapeutics Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
10.2.5 Affinia Therapeutics Recent Development
10.3 Spark Therapeutics
10.3.1 Spark Therapeutics Company Details
10.3.2 Spark Therapeutics Business Overview
10.3.3 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Introduction
10.3.4 Spark Therapeutics Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
10.3.5 Spark Therapeutics Recent Development
10.4 AGC Biologics
10.4.1 AGC Biologics Company Details
10.4.2 AGC Biologics Business Overview
10.4.3 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Introduction
10.4.4 AGC Biologics Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
10.4.5 AGC Biologics Recent Development
10.5 StrideBio
10.5.1 StrideBio Company Details
10.5.2 StrideBio Business Overview
10.5.3 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Introduction
10.5.4 StrideBio Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
10.5.5 StrideBio Recent Development
10.6 SIRION Biotech
10.6.1 SIRION Biotech Company Details
10.6.2 SIRION Biotech Business Overview
10.6.3 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Introduction
10.6.4 SIRION Biotech Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
10.6.5 SIRION Biotech Recent Development
10.7 Neurophth Biotechnology
10.7.1 Neurophth Biotechnology Company Details
10.7.2 Neurophth Biotechnology Business Overview
10.7.3 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Introduction
10.7.4 Neurophth Biotechnology Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
10.7.5 Neurophth Biotechnology Recent Development
10.8 Belief BioMed
10.8.1 Belief BioMed Company Details
10.8.2 Belief BioMed Business Overview
10.8.3 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Introduction
10.8.4 Belief BioMed Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
10.8.5 Belief BioMed Recent Development
10.9 BiBo Biopharma Engineering Co., LTD.
10.9.1 BiBo Biopharma Engineering Co., LTD. Company Details
10.9.2 BiBo Biopharma Engineering Co., LTD. Business Overview
10.9.3 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Introduction
10.9.4 BiBo Biopharma Engineering Co., LTD. Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
10.9.5 BiBo Biopharma Engineering Co., LTD. Recent Development
10.10 Beihai Kangcheng
10.10.1 Beihai Kangcheng Company Details
10.10.2 Beihai Kangcheng Business Overview
10.10.3 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Introduction
10.10.4 Beihai Kangcheng Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
10.10.5 Beihai Kangcheng Recent Development
10.11 PackGene Biotech
10.11.1 PackGene Biotech Company Details
10.11.2 PackGene Biotech Business Overview
10.11.3 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Introduction
10.11.4 PackGene Biotech Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
10.11.5 PackGene Biotech Recent Development
10.12 Sarepta Therapeutics
10.12.1 Sarepta Therapeutics Company Details
10.12.2 Sarepta Therapeutics Business Overview
10.12.3 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Introduction
10.12.4 Sarepta Therapeutics Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
10.12.5 Sarepta Therapeutics Recent Development
10.13 Carbon BioSciences
10.13.1 Carbon BioSciences Company Details
10.13.2 Carbon BioSciences Business Overview
10.13.3 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Introduction
10.13.4 Carbon BioSciences Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
10.13.5 Carbon BioSciences Recent Development
10.14 Kelonia Therapeutics
10.14.1 Kelonia Therapeutics Company Details
10.14.2 Kelonia Therapeutics Business Overview
10.14.3 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Introduction
10.14.4 Kelonia Therapeutics Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
10.14.5 Kelonia Therapeutics Recent Development
10.15 Roche
10.15.1 Roche Company Details
10.15.2 Roche Business Overview
10.15.3 Roche Adeno-Associated Virus (AAV) Gene Therapy Introduction
10.15.4 Roche Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
10.15.5 Roche Recent Development
10.16 Remedium Bio
10.16.1 Remedium Bio Company Details
10.16.2 Remedium Bio Business Overview
10.16.3 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Introduction
10.16.4 Remedium Bio Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
10.16.5 Remedium Bio Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
List of Figures
List of Tables
Table 1. Adeno-Associated Virus (AAV) Gene Therapy Market Size United States VS Global, CAGR (2018 VS 2022 VS 2029)
Table 2. Adeno-Associated Virus (AAV) Gene Therapy Market Trends
Table 3. Adeno-Associated Virus (AAV) Gene Therapy Market Drivers
Table 4. Adeno-Associated Virus (AAV) Gene Therapy Market Challenges
Table 5. Adeno-Associated Virus (AAV) Gene Therapy Market Restraints
Table 6. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. United States Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. United States Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Key Companies of Adeno-Associated Virus (AAV) Gene Therapy, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Share by Player, 2018-2023
Table 13. Global Adeno-Associated Virus (AAV) Gene Therapy Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Adeno-Associated Virus (AAV) Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adeno-Associated Virus (AAV) Gene Therapy as of 2022)
Table 15. Global Key Players of Adeno-Associated Virus (AAV) Gene Therapy, Headquarters and Area Served
Table 16. Global Key Players of Adeno-Associated Virus (AAV) Gene Therapy, Product and Application
Table 17. Global Key Players of Adeno-Associated Virus (AAV) Gene Therapy, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Adeno-Associated Virus (AAV) Gene Therapy in United States, Ranked by Revenue (2022) & (US$ Million)
Table 20. United States Adeno-Associated Virus (AAV) Gene Therapy Revenue by Players, (US$ Million), 2021, 2022 & 2023
Table 21. United States Adeno-Associated Virus (AAV) Gene Therapy Revenue Share by Players, 2021, 2022 & 2023
Table 22. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 23. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Region (2024-2029) & (US$ Million)
Table 25. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 27. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 29. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 30. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 32. EMEA Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 34. EMEA Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 36. EMEA Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. EMEA Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 39. China Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 41. China Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 43. China Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 46. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 48. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 49. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 51. Creative Biolabs Company Details
Table 52. Creative Biolabs Business Overview
Table 53. Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Product
Table 54. Creative Biolabs Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023) & (US$ Million)
Table 55. Creative Biolabs Recent Development
Table 56. Affinia Therapeutics Company Details
Table 57. Affinia Therapeutics Business Overview
Table 58. Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product
Table 59. Affinia Therapeutics Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023) & (US$ Million)
Table 60. Affinia Therapeutics Recent Development
Table 61. Spark Therapeutics Company Details
Table 62. Spark Therapeutics Business Overview
Table 63. Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product
Table 64. Spark Therapeutics Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023) & (US$ Million)
Table 65. Spark Therapeutics Recent Development
Table 66. AGC Biologics Company Details
Table 67. AGC Biologics Business Overview
Table 68. AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Product
Table 69. AGC Biologics Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023) & (US$ Million)
Table 70. AGC Biologics Recent Development
Table 71. StrideBio Company Details
Table 72. StrideBio Business Overview
Table 73. StrideBio Adeno-Associated Virus (AAV) Gene Therapy Product
Table 74. StrideBio Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023) & (US$ Million)
Table 75. StrideBio Recent Development
Table 76. SIRION Biotech Company Details
Table 77. SIRION Biotech Business Overview
Table 78. SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Product
Table 79. SIRION Biotech Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023) & (US$ Million)
Table 80. SIRION Biotech Recent Development
Table 81. Neurophth Biotechnology Company Details
Table 82. Neurophth Biotechnology Business Overview
Table 83. Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Product
Table 84. Neurophth Biotechnology Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023) & (US$ Million)
Table 85. Neurophth Biotechnology Recent Development
Table 86. Belief BioMed Company Details
Table 87. Belief BioMed Business Overview
Table 88. Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Product
Table 89. Belief BioMed Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023) & (US$ Million)
Table 90. Belief BioMed Recent Development
Table 91. BiBo Biopharma Engineering Co., LTD. Company Details
Table 92. BiBo Biopharma Engineering Co., LTD. Business Overview
Table 93. BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Product
Table 94. BiBo Biopharma Engineering Co., LTD. Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023) & (US$ Million)
Table 95. BiBo Biopharma Engineering Co., LTD. Recent Development
Table 96. Beihai Kangcheng Company Details
Table 97. Beihai Kangcheng Business Overview
Table 98. Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Product
Table 99. Beihai Kangcheng Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023) & (US$ Million)
Table 100. Beihai Kangcheng Recent Development
Table 101. PackGene Biotech Company Details
Table 102. PackGene Biotech Business Overview
Table 103. PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Product
Table 104. PackGene Biotech Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023) & (US$ Million)
Table 105. PackGene Biotech Recent Development
Table 106. Sarepta Therapeutics Company Details
Table 107. Sarepta Therapeutics Business Overview
Table 108. Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product
Table 109. Sarepta Therapeutics Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023) & (US$ Million)
Table 110. Sarepta Therapeutics Recent Development
Table 111. Carbon BioSciences Company Details
Table 112. Carbon BioSciences Business Overview
Table 113. Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Product
Table 114. Carbon BioSciences Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023) & (US$ Million)
Table 115. Carbon BioSciences Recent Development
Table 116. Kelonia Therapeutics Company Details
Table 117. Kelonia Therapeutics Business Overview
Table 118. Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product
Table 119. Kelonia Therapeutics Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023) & (US$ Million)
Table 120. Kelonia Therapeutics Recent Development
Table 121. Roche Company Details
Table 122. Roche Business Overview
Table 123. Roche Adeno-Associated Virus (AAV) Gene Therapy Product
Table 124. Roche Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023) & (US$ Million)
Table 125. Roche Recent Development
Table 126. Remedium Bio Company Details
Table 127. Remedium Bio Business Overview
Table 128. Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Product
Table 129. Remedium Bio Revenue in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023) & (US$ Million)
Table 130. Remedium Bio Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Adeno-Associated Virus (AAV) Gene Therapy Product Picture
Figure 2. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size 2018-2029 (US$ Million)
Figure 4. United States Adeno-Associated Virus (AAV) Gene Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 5. United States Adeno-Associated Virus (AAV) Gene Therapy Market Size 2018-2029 (US$ Million)
Figure 6. United States Adeno-Associated Virus (AAV) Gene Therapy Market Share in Global 2018-2029
Figure 7. Adeno-Associated Virus (AAV) Gene Therapy Report Years Considered
Figure 8. Product Picture of Luxturna
Figure 9. Product Picture of Zolgensma
Figure 10. Product Picture of Others
Figure 11. Global Adeno-Associated Virus (AAV) Gene Therapy Market Share by Type in 2022 & 2029
Figure 12. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2029) & (US$ Million)
Figure 13. Global Adeno-Associated Virus (AAV) Gene Therapy Market Share by Type (2018-2029)
Figure 14. United States Adeno-Associated Virus (AAV) Gene Therapy Market Share by Type in 2022 & 2029
Figure 15. United States Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2029) & (US$ Million)
Figure 16. United States Adeno-Associated Virus (AAV) Gene Therapy Market Share by Type (2018-2029)
Figure 17. Product Picture of Central Nervous System Diseases
Figure 18. Product Picture of Ocular Diseases
Figure 19. Product Picture of Liver-directed Diseases
Figure 20. Product Picture of Other Hereditary Diseases
Figure 21. Global Adeno-Associated Virus (AAV) Gene Therapy Market Share by Application in 2022 & 2029
Figure 22. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2029) & (US$ Million)
Figure 23. Global Adeno-Associated Virus (AAV) Gene Therapy Market Share by Application (2018-2029)
Figure 24. United States Adeno-Associated Virus (AAV) Gene Therapy Market Share by Application in 2022 & 2029
Figure 25. United States Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2029) & (US$ Million)
Figure 26. United States Adeno-Associated Virus (AAV) Gene Therapy Market Share by Application (2018-2029)
Figure 27. The Top 5 and 10 Largest Companies of Adeno-Associated Virus (AAV) Gene Therapy in the World: Market Share by Adeno-Associated Virus (AAV) Gene Therapy Revenue in 2022
Figure 28. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Region: 2018 VS 2022 VS 2029
Figure 29. Global Adeno-Associated Virus (AAV) Gene Therapy Market Share by Region (2018-2029)
Figure 30. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate 2018-2029 (US$ Million)
Figure 31. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Share by Type (2018-2029)
Figure 32. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Share by Application (2018-2029)
Figure 33. United States Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 34. Canada Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 35. Mexico Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 36. Brazil Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 37. EMEA Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate 2018-2029 (US$ Million)
Figure 38. EMEA Adeno-Associated Virus (AAV) Gene Therapy Market Share by Type (2018-2029)
Figure 39. EMEA Adeno-Associated Virus (AAV) Gene Therapy Market Share by Application (2018-2029)
Figure 40. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 41. Middle East Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 42. Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate 2018-2029 (US$ Million)
Figure 44. China Adeno-Associated Virus (AAV) Gene Therapy Market Share by Type (2018-2029)
Figure 45. China Adeno-Associated Virus (AAV) Gene Therapy Market Share by Application (2018-2029)
Figure 46. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate 2018-2029 (US$ Million)
Figure 47. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Share by Type (2018-2029)
Figure 48. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Share by Application (2018-2029)
Figure 49. Japan Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 50. South Korea Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 51. China Taiwan Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 52. Southeast Asia Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 53. India Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 54. Creative Biolabs Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
Figure 55. Affinia Therapeutics Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
Figure 56. Spark Therapeutics Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
Figure 57. AGC Biologics Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
Figure 58. StrideBio Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
Figure 59. SIRION Biotech Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
Figure 60. Neurophth Biotechnology Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
Figure 61. Belief BioMed Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
Figure 62. BiBo Biopharma Engineering Co., LTD. Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
Figure 63. Beihai Kangcheng Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
Figure 64. PackGene Biotech Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
Figure 65. Sarepta Therapeutics Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
Figure 66. Carbon BioSciences Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
Figure 67. Kelonia Therapeutics Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
Figure 68. Roche Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
Figure 69. Remedium Bio Revenue Growth Rate in Adeno-Associated Virus (AAV) Gene Therapy Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
